Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
321.00    -4.00 (-1.23%)
Bid:
314.00
Ask:
328.00
Spread: 14.00 (4.459%)
Market Cap: £40.73m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Directorate Change

26 Jun 2020 07:00

RNS Number : 1512R
System1 Group PLC
26 June 2020
 

System1 Group PLC (AIM: SYS1)

("System1", or "the Company", or "the Group")

 

26 June 2020

 

Appointment of new executive director

 

Further to the announcement dated 3 April 2020, System1 Group plc (AIM: SYS1) today announces that it has appointed Chris Willford to the board of directors of the Company as an executive director with immediate effect.

 

Chris built his career with blue chip consumer businesses including Unilever, British Airways (Group Treasurer), Barclays (Finance director of Corporate Bank and UK Retail Bank) and Bradford & Bingley (Group Finance Director). In the past decade, Chris has worked as a consultant with a portfolio of scale up media and tech businesses similar to System1.

 

Further details in respect of Chris Willford, as required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, are as set out below.

 

Additional Information

 

Christopher Patrick Willford, age 57, is currently or has been a director of the following companies within the past five years:

 

Current Directorships

Previous directorships

Radix Holdings Limited

None

Veradix Ltd

 

Causaradix Ltd

 

My Wealth Cloud Ltd.

 

Old Warwickian Trust

 

 

 

The Company is required to make the following statement in accordance with Schedule Two paragraph (g) (viii) of the AIM Rules for Companies:

 

On 11 December 2013, the Financial Conduct Authority ("FCA") published a final notice in relation to an investigation into Chris Willford whilst he was finance director at Bradford & Bingley plc ("BBG") in 2008. Mr Willford was fined £30,000 by the FCA for breaching Principle 6 of the FCA's Statements of Principle for Approved Persons as a result of Mr Willford's conduct in his performance of the CF1 Director function as Group Finance Director at BBG during the period between 16 May 2008 and 19 May 2008.

https://www.fca.org.uk/publication/final-notices/christopher-willford.pdf

 

On 10 July 2014, the Financial Reporting Council ("FRC") published the outcome of its disciplinary case against Mr Willford in respect of adverse findings made in the FCA Final Notice published on 11 December 2013. The FRC found that the adverse findings were conclusive evidence of misconduct and Mr Willford was reprimanded and fined £13,000.

https://www.frc.org.uk/news/july-2014/outcome-of-disciplinary-case-against-christopher-w

 

 

 

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

The Company can be found at www.system1group.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFELLLBQLXBBD
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.